AstraZeneca PLC:企業のM&A・事業提携・投資動向

◆英語タイトル:AstraZeneca PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2039
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:1071
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

AstraZeneca PLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s AstraZeneca PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by AstraZeneca PLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes AstraZeneca PLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by AstraZeneca PLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on AstraZeneca PLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by AstraZeneca PLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for AstraZeneca PLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about AstraZeneca PLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 10
Mergers and Acquisitions – Overview 10
Mergers and Acquisitions – Deal reports 11
CORPORATE VENTURING 79
Corporate Venturing – Overview 79
Corporate Venturing – Deal reports 80
PARTNERSHIP 86
Partnership – Overview 86
Partnership – Deal reports 87
CAPITAL RAISING 1029
Capital Raising – Overview 1029
Capital Raising – Deal reports 1030
DIVESTMENTS 1032
Divestments – Overview 1032
Divestments – Deal reports 1033
APPENDIX 1061
Contact Us 1061
About MarketLine Financial Deals Database 1061
Deal Definition and Methodology 1063
About MarketLine 1070

List of Tables
Table 1: AstraZeneca PLC M&A volume and value trend (2014-YTD2018)
Table 2: AstraZeneca PLC M&A activity by geography (2014-YTD2018)
Table 3: AstraZeneca PLC corporate venturing volume and value trend (2014-YTD2018)
Table 4: AstraZeneca PLC corporate venturing by geography (2014-YTD2018)
Table 5: AstraZeneca PLC partnership volume and value trend (2014-YTD2018)
Table 6: AstraZeneca PLC partnership trend by key deal type (2014-YTD2018)
Table 7: AstraZeneca PLC capital raising volume and value trend (2014-YTD2018)
Table 8: AstraZeneca PLC capital raising by deal type (2014-YTD2018)
Table 9: AstraZeneca PLC divestments volume and value trend (2014-YTD2018)
Table 10: AstraZeneca PLC divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: AstraZeneca PLC M&A volume and value trend (2014-YTD2018)
Figure 2: AstraZeneca PLC M&A activity by geography (2014-YTD2018)
Figure 3: AstraZeneca PLC corporate venturing volume and value trend (2014-YTD2018)
Figure 4: AstraZeneca PLC corporate venturing by geography (2014-YTD2018)
Figure 5: AstraZeneca PLC partnership volume and value trend (2014-YTD2018)
Figure 6: AstraZeneca PLC partnership trend by key deal type (2014-YTD2018)
Figure 7: AstraZeneca PLC capital raising volume and value trend (2014-YTD2018)
Figure 8: AstraZeneca PLC capital raising by deal type (2014-YTD2018)
Figure 9: AstraZeneca PLC divestments volume and value trend (2014-YTD2018)
Figure 10: AstraZeneca PLC divestments by geography (2014-YTD2018)

★海外企業調査レポート[AstraZeneca PLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Just Eat Plc:企業の戦略・SWOT・財務分析
    Just Eat Plc - Strategy, SWOT and Corporate Finance Report Summary Just Eat Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Rockhopper Exploration Plc (RKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • Probi AB (PROB):企業の財務・戦略的SWOT分析
    Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PT Dirgantara Indonesia:企業の戦略・SWOT・財務情報
    PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nordion (Canada) Inc:企業の戦略的SWOT分析
    Nordion (Canada) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nuvo Pharmaceuticals Inc (NRI)-製薬・医療分野:企業M&A・提携分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly known as Nuvo Research Inc is a drug company that offers topical pain products and technologies. The company’s product portfolio includes pennsaid, pennsaid 2%, and heated lidocaine and tetracaine patches. Its products deliver drugs topically into an …
  • Amazon.com, Inc.:戦略・SWOT・企業財務分析
    Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Timken Company:企業の戦略・SWOT・財務分析
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SPAR Osterreichische Warenhandels AG:企業の戦略的SWOT分析
    SPAR Osterreichische Warenhandels AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Taghleef Industries L.L.C.
    Taghleef Industries L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Taghleef Industries L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Electro Optic Systems Holdings Ltd (EOS):企業の財務・戦略的SWOT分析
    Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ConMed Corp (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Petroleo Brasileiro SA (PETR4):石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleo Brasileiro SA (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing, trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical businesses, …
  • Jackson Electric Membership Corp:企業の戦略的SWOT分析
    Jackson Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Meidensha Corporation:企業の戦略・SWOT・財務分析
    Meidensha Corporation - Strategy, SWOT and Corporate Finance Report Summary Meidensha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Duke Energy Florida LLC:企業の戦略的SWOT分析
    Duke Energy Florida LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Vermilion Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Vermilion Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Vermilion Energy Inc (Vermilion) is an oil and gas company that offers exploration and production services. The company is an oil and gas producer in Alberta. It offers production programs focus …
  • Theravance Biopharma Inc (TBPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Theravance Biopharma Inc (Theravance Biopharma) is a diversified biopharmaceutical company. Its flagship product, Vibativ (telavancin) is a bactericidal, once-daily injectable antibiotic to treat patients with serious, life-threatening infections due to Staphylococcus aureus and other Gram-p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆